Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4605099

Cl.ClCC(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11437100 1.00
Methane SCHEMBL27978512 0.95
SCHEMBL28154792 0.94 TSHR (0.40)
SCHEMBL16435 0.94
Ethylene SCHEMBL27323973 0.91
SCHEMBL11822312 0.89
Methylene Chloride SCHEMBL5785447 0.89
Ammonia Solution, Strong SCHEMBL6917054 0.89
Chloroform SCHEMBL4937516 0.89
Water SCHEMBL6706113 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987850-B1 Reinforced tissue implants and methods of manufacture and use ETHICON INC (US) 2016-06-29 EP disclosed
US-8691259-B2 Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration DEPUY MITEK, LLC (US) 2014-04-08 US disclosed
EP-1987850-A1 Reinforced tissue implants and methods of manufacture and use Ethicon, Incorporated (US) 2008-11-05 EP disclosed
EP-1216717-B1 Method of making a reinforced tissue implant ETHICON INC (US) 2008-07-09 EP disclosed
US-20060067967-A1 Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration DEPUY MITEK, INC. (US) 2006-03-30 US disclosed
US-6884428-B2 Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration DEPUY MITEK, INC. (US) 2005-04-26 US disclosed
US-6852330-B2 Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration DEPUY MITEK, INC. (US) 2005-02-08 US disclosed
EP-1216718-B1 Reinforced foam implants for soft tissue repair and regeneration ETHICON INC (US) 2004-10-06 EP disclosed
US-20030193104-A1 Reinforced tissue implants and methods of manufacture and use MELICAN MORA CAROLYNNE (US) 2003-10-16 US disclosed
US-20030147935-A1 Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration ETHICON, INC. (US) 2003-08-07 US disclosed
US-6599323-B2 Biocompatible tissue implant comprising bioabsorbable polymeric foam having open cell pore structure and reinforcement formed of biocompatible mesh-containing material, in which pores of foam penetrate mesh and interlock ETHICON, INC. 2003-07-29 US disclosed
US-20020127265-A1 Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration DEPUY MITEK, LLC 2002-09-12 US disclosed
US-20020119177-A1 Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration DEPUY MITEK HOLDING CORPORATION 2002-08-29 US disclosed
US-20020120348-A1 Reinforced tissue implants and methods of manufacture and use ETHICON, INC. 2002-08-29 US disclosed
EP-1216718-A1 Reinforced foam implants for soft tissue repair and regeneration ETHICON, INC. (US) 2002-06-26 EP disclosed
EP-1216717-A1 Reinforced tissue implants and methods of manufacture and use ETHICON, INC. (US) 2002-06-26 EP disclosed
EP-0288876-B1 Electrophotographic plate HITACHI CHEMICAL CO LTD (JP) 1994-07-20 EP disclosed
EP-0288876-A2 Electrophotographic plate Hitachi Chemical Co., Ltd. (JP) 1988-11-02 EP disclosed